R&D

Benchling, the biotechnology cloud R&D platform used by organisations including Regeneron, Gilead and Pfizer, hosted a virtual event on September 14 at 8 am PT / 11 am ET called Drive Innovation from Discovery to Development, where the company announced its entry into the Early Development market, launching new solutions that allow scientists to move from research through development within […]

Following the announcement by Samsung Biologics that it planned to add mRNA vaccine drug substance manufacturing services to its offering, DDW’s Megan Thomas spoke to Seahee Kim about what this means for both business and drug development.   MT: As a CDMO, Samsung Biologics can offer both development and manufacturing services. What are the advantages of […]

The Bloomsbury SET, a knowledge exchange programme led by The Royal Veterinary College (RVC), has been awarded £1.9 million from Research England. Beginning in July 2021, the year-long project aims to commercialise research into infectious disease and antimicrobial resistance. Building on the current work of The Bloomsbury SET, this new programme, entitled “The Bloomsbury SET: […]

The UK government has released a national statistics report, “Annual Statistics of Scientific Procedures on Living Animals, Great Britain, 2020”. DDW recently reported the ABPI comment. The medical research charity FRAME’s Education & Outreach Manager Amy Beale has made further comment. Beale said: “Whilst the headline figures in the Annual Statistics for 2020 are encouraging […]

Exscientia and GT Apeiron Therapeutics have entered an R&D collaboration. Exscientia’s AI expertise will  be used to accelerate the discovery of multiple small molecule therapeutic drug candidates designed to selectively treat aberrant cell cycle driven cancers and build a pipeline of CDK novel therapies. This collaboration follows the design of multiple selective CDK7 compounds. The […]

The UK government has released a national statistics report, “Annual Statistics of Scientific Procedures on Living Animals, Great Britain, 2020”. In summary, 2.88 million procedures were carried out in Great Britain involving living animals in 2020. Key results of the report include the fact that the 2.88 million procedures in 2020 is a decrease of […]

Listen to this article on the DDW Podcast: Steve Gardner, CEO PrecisionLife, examines the lack of return on investment for pharmaceutical R&D and the huge pockets of unmet medical need in common chronic disorders. Over the last decade many pharma companies such as GSK, Abbvie and AZ have analysed the success factors for their drug discovery […]

Abcam has opened a new site in Waltham, MA. The facility is a central part of Abcam’s growth in the US and will serve as a hub for its R&D and commercial activities in the region. “Abcam’s first step toward global expansion was in 2003 at Kendall Square.  Since then, the US has become our […]

LifeNet Health has expanded its LifeSciences division offering human cell- and tissue-based research solutions through a new website, LNHLifeSciences.org. LifeNet Health says it has recovery, handling and preservation protocols — assuring tissue integrity and quality are sustained throughout the entire process. The organisation offers expertise with the recovery of an extensive range of healthy and […]